Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Jahan M) > Safety and efficacy...

Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01) : a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Benatar, Michael (författare): Department of Neurology, University of Miami Miller School of Medicine, FL, Miami, United States

Hansen, Thomas (författare): Orphazyme, Copenhagen, Denmark

Rom, Dror (författare): Prosoft Clinical, PA, Chesterbrook, United States

visa fler...

Geist, Marie A (författare): Orphazyme, Copenhagen, Denmark

Blaettler, Thomas (författare): Orphazyme, Copenhagen, Denmark

Camu, William (författare): Department of Neurology University of Montpellier, CHU Montpellier, INM INSERM, Montpellier, France

Kuzma-Kozakiewicz, Magdalena (författare): Department of Neurology, Medical University of Warsaw, Warsaw, Poland

van den Berg, Leonard H (författare): Department of Neurology, University Medical Center Utrecht, Utrecht, Netherlands

Morales, Raul Juntas (författare): Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain

Chio, Adriano (författare): Rita Levi Montalcini Department of Neuroscience, University of Torino, Torino, Italy

Andersen, Peter M., 1962- (författare): Umeå universitet,Neurovetenskaper

Pradat, Pierre-Francois (författare): APHP, Department of Neurology, Hôpital Pitié-Salpêtrière, Paris, France

Lange, Dale (författare): Department of Neurology, Hospital for Special Surgery, NY, New York, United States

Van Damme, Philip (författare): Department of Neurology, University Hospital Leuven, KU Leuven, Leuven, Belgium

Mora, Gabriele (författare): Istituti Clinici Scientifici Maugeri, IRCCS Milano, Milan, Italy

Grudniak, Mariusz (författare): Research and Development Department, Polish Stem Cell Bank, Warsaw, Poland

Elliott, Matthew (författare): University of Virginia Medical Center, VA, Charlottesville, United States

Petri, Susanne (författare): Department of Neurology, Hannover Medical School, Hannover, Germany

Olney, Nicholas (författare): Providence Portland Medical Center, Providence Brain and Spine Institute, OR, Portland, United States

Ladha, Shafeeq (författare): Department of Neurology, Barrow Neurological Institute, AZ, Phoenix, United States

Goyal, Namita A (författare): Department of Neurology, University of California Irvine, CA, Irvine, United States

Meyer, Thomas (författare): Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany

Hanna, Michael G (författare): University College London, National Hospital for Neurology and Neurosurgery, London, United Kingdom

Quinn, Colin (författare): Department of Neurology, Perelman School of Medicine, University of Pennsylvania, PA, Philadelphia, United States

Genge, Angela (författare): Department of Neurology, Montreal Neurological Institute, QC, Montreal, Canada

Zinman, Lorne (författare): Sunnybrook Health Sciences Centre, ON, Toronto, Canada

Jabari, Duaa (författare): Department of Neurology, The University of Kansas Medical Center, KS, Kansas City, United States

Shoesmith, Christen (författare): Department of Clinical Neurological Sciences, London Health Sciences Centre, Western University, ON, London, Canada

Ludolph, Albert C (författare): Department of Neurology, University of Ulm, Ulm, Germany

Neuwirth, Christoph (författare): Neuromuscular Disease Unit/ALS Clinic, Kantonspital St Gallen, St Gallen, Switzerland

Nations, Sharon (författare): University of Texas Southwestern, TX, Dallas, United States

Shefner, Jeremy M (författare): Department of Neurology, Barrow Neurological Institute, AZ, Phoenix, United States

Turner, Martin R (författare): Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom

Wuu, Joanne (författare): Department of Neurology, University of Miami Miller School of Medicine, FL, Miami, United States

Bennett, Richard (författare): Orphazyme, Copenhagen, Denmark

Dang, Hoang (författare): Orphazyme, Copenhagen, Denmark

Sundgreen, Claus (författare): Orphazyme, Copenhagen, Denmark

Granit, Volkan (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Steele, Julie (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Levy, Wendy (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Paredes, Maria Elena (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Hernandez, Jessica (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Bilsker, Martin (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Szacka, Katarzyna (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Ronert, Adam (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Jablońska, Dorota (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Łuczak, Alina Zuzanna (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Chaverri, Delia (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Janse van Mantgem, Mark R (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Bunte, Tommy M (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Broere, Bianca (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

de Fockert, Arianne (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Sanchez-Tejerina, Daniel (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Landabaso, Carmen (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Calvo, Andrea (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Moglia, Cristina (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Manera, Umberto (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Canosa, Antonio (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Vasta, Rosario (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Salamone, Paolina (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Fuda, Giuseppe (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

DeMarco, Giovanni (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Casale, Federico (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

ME Forsberg, Karin (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Winroth, Ivar (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Almgren Stenberg, Erica (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Holmgren, Monica (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Amador, Maria del Mar (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Lenglet, Timothee (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Querin, Giorgia (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Coudoin, Sylvie (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Pavlakis, Pantelis (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Holzberg, Shara (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Sideri, Riccardo (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Marinou, Kalliopi (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Czarnecki, Maciej (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Ługiewicz, Renata (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Biel-Czarnecka, Marta (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Boczkowska, Marcelina (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Schotte, Caroline (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Vynckier, Jan (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Van Daele, Sien (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Claeys, Thomas (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Delmotte, Koen (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Swinnen, Bart (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Serrien, Anouk (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

D'Hondt, Ann (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Lamaire, Nikita (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Debien, Elisa (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Jones, Sarah (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Vachon, Chris (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Grogan, James (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Solorzano, Guillermo (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Crowell, Allison (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Rakocevic, Goran (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Wagoner, Mary (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Alma, Osmanovic (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Flavia, Wiehler (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Sonja, Körner (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Olivia, Schreiber-Katz (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Camilla, Wohnrade (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Anastasia, Sarikidi (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Carola, Kassebaum (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Chantal, Fischer (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Adamo, Ashley (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Turcotte, Nicole (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Duncan, Jessie (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Turner, Ivone (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Elman, Lauren (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Massie, Rami (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Berube, Maxime (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Saunders, Natalie (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Salmon, Kristiana (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Foucher, Juliette (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Agessandro, Abrahao (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Shirley, Pham (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Jahan, Mookshah (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Phung, Liane (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Statland, Jeffrey (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Jawdat, Omar (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Dimachkie, Mazen (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Pasnoor, Mamatha (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Farmakidis, Constantine (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Heim, Andrew (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Lillig, Katie (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Lackey, Alyssa (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Weber, Markus (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Kurz, Martina (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

Levine, Todd (författare): [NO CONNECTION TO ANY AFFILIATION IN XML]

visa färre...

(creator_code:org_t)

Elsevier, 2024
2024
Engelska.
Ingår i: Lancet Neurology. - : Elsevier. - 1474-4422 .- 1474-4465. ; 23:7, s. 687-699

Relaterad länk:: https://urn.kb.se/re...; visa fler...; https://doi.org/10.1...; visa färre...

Tidskriftsartikel (refereegranskat)

Abstract Ämnesord

Stäng

Background: Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder leading to muscle weakness and respiratory failure. Arimoclomol, a heat-shock protein-70 (HSP70) co-inducer, is neuroprotective in animal models of amyotrophic lateral sclerosis, with multiple mechanisms of action, including clearance of protein aggregates, a pathological hallmark of sporadic and familial amyotrophic lateral sclerosis. We aimed to evaluate the safety and efficacy of arimoclomol in patients with amyotrophic lateral sclerosis.Methods: ORARIALS-01 was a multinational, randomised, double-blind, placebo-controlled, parallel-group trial done at 29 centres in 12 countries in Europe and North America. Patients were eligible if they were aged 18 years or older and met El Escorial criteria for clinically possible, probable, probable laboratory-supported, definite, or familial amyotrophic lateral sclerosis; had an ALS Functional Rating Scale-Revised score of 35 or more; and had slow vital capacity at 70% or more of the value predicted on the basis of the participant's age, height, and sex. Patients were randomly assigned (2:1) in blocks of 6, stratified by use of a stable dose of riluzole or no riluzole use, to receive oral arimoclomol citrate 1200 mg/day (400 mg three times per day) or placebo. The Randomisation sequence was computer generated centrally. Investigators, study personnel, and study participants were masked to treatment allocation. The primary outcome was the Combined Assessment of Function and Survival (CAFS) rank score over 76 weeks of treatment. The primary outcome and safety were analysed in the modified intention-to-treat population. This trial is registered with ClinicalTrials.gov, NCT03491462, and is completed.Findings: Between July 31, 2018, and July 17, 2019, 287 patients were screened, 245 of whom were enrolled in the trial and randomly assigned. The modified intention-to-treat population comprised 239 patients (160 in the arimoclomol group and 79 in the placebo group): 151 (63%) were male and 88 (37%) were female; mean age was 57·6 years (SD 10·9). CAFS score over 76 weeks did not differ between groups (mean 0·51 [SD 0·29] in the arimoclomol group vs 0·49 [0·28] in the placebo group; p=0·62). Cliff's delta comparing the two groups was 0·039 (95% CI –0·116 to 0·194). Proportions of participants who died were similar between the treatment groups: 29 (18%) of 160 patients in the arimoclomol group and 18 (23%) of 79 patients in the placebo group. Most deaths were due to disease progression. The most common adverse events were gastrointestinal. Adverse events were more often deemed treatment-related in the arimoclomol group (104 [65%]) than in the placebo group (41 [52%]) and more often led to treatment discontinuation in the arimoclomol group (26 [16%]) than in the placebo group (four [5%]).Interpretation: Arimoclomol did not improve efficacy outcomes compared with placebo. Although available biomarker data are insufficient to preclude future strategies that target the HSP response, safety data suggest that a higher dose of arimoclomol would not have been tolerated.Funding: Orphazyme.

Hitta via bibliotek

Lancet Neurology (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...: Benatar, Michael; Hansen, Thomas; Rom, Dror; Geist, Marie A; Blaettler, Thoma ...; Camu, William; visa fler...; Kuzma-Kozakiewic ...; van den Berg, Le ...; Morales, Raul Ju ...; Chio, Adriano; Andersen, Peter ...; Pradat, Pierre-F ...; Lange, Dale; Van Damme, Phili ...; Mora, Gabriele; Grudniak, Marius ...; Elliott, Matthew; Petri, Susanne; Olney, Nicholas; Ladha, Shafeeq; Goyal, Namita A; Meyer, Thomas; Hanna, Michael G; Quinn, Colin; Genge, Angela; Zinman, Lorne; Jabari, Duaa; Shoesmith, Chris ...; Ludolph, Albert ...; Neuwirth, Christ ...; Nations, Sharon; Shefner, Jeremy ...; Turner, Martin R; Wuu, Joanne; Bennett, Richard; Dang, Hoang; Sundgreen, Claus; Granit, Volkan; Steele, Julie; Levy, Wendy; Paredes, Maria E ...; Hernandez, Jessi ...; Bilsker, Martin; Szacka, Katarzyn ...; Ronert, Adam; Jablońska, Dorot ...; Łuczak, Alina Zu ...; Chaverri, Delia; Janse van Mantge ...; Bunte, Tommy M; Broere, Bianca; de Fockert, Aria ...; Sanchez-Tejerina ...; Landabaso, Carme ...; Calvo, Andrea; Moglia, Cristina; Manera, Umberto; Canosa, Antonio; Vasta, Rosario; Salamone, Paolin ...; Fuda, Giuseppe; DeMarco, Giovann ...; Casale, Federico; ME Forsberg, Kar ...; Winroth, Ivar; Almgren Stenberg ...; Holmgren, Monica; Amador, Maria de ...; Lenglet, Timothe ...; Querin, Giorgia; Coudoin, Sylvie; Pavlakis, Pantel ...; Holzberg, Shara; Sideri, Riccardo; Marinou, Kalliop ...; Czarnecki, Macie ...; Ługiewicz, Renat ...; Biel-Czarnecka, ...; Boczkowska, Marc ...; Schotte, Carolin ...; Vynckier, Jan; Van Daele, Sien; Claeys, Thomas; Delmotte, Koen; Swinnen, Bart; Serrien, Anouk; D'Hondt, Ann; Lamaire, Nikita; Debien, Elisa; Jones, Sarah; Vachon, Chris; Grogan, James; Solorzano, Guill ...; Crowell, Allison; Rakocevic, Goran; Wagoner, Mary; Alma, Osmanovic; Flavia, Wiehler; Sonja, Körner; Olivia, Schreibe ...; Camilla, Wohnrad ...; Anastasia, Sarik ...; Carola, Kassebau ...; Chantal, Fischer; Adamo, Ashley; Turcotte, Nicole; Duncan, Jessie; Turner, Ivone; Elman, Lauren; Massie, Rami; Berube, Maxime; Saunders, Natali ...; Salmon, Kristian ...; Foucher, Juliett ...; Agessandro, Abra ...; Shirley, Pham; Jahan, Mookshah; Phung, Liane; Statland, Jeffre ...; Jawdat, Omar; Dimachkie, Mazen; Pasnoor, Mamatha; Farmakidis, Cons ...; Heim, Andrew; Lillig, Katie; Lackey, Alyssa; Weber, Markus; Kurz, Martina; Levine, Todd; visa färre...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Neurologi

Artiklar i publikationen: Lancet Neurology

Av lärosätet: Umeå universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se

Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01) : a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Ämnesord

Publikations- och innehållstyp

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Sök utanför SwePub